Mucosal vaccination against tuberculosis using inert bioparticles. - Wikidata - awgldk - TriplyDB

Mucosal vaccination against tuberculosis using inert bioparticles.

Mucosal vaccination against tuberculosis using inert bioparticles.

http://www.wikidata.org/entity/Q37264883

about

Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidates Localization of a red fluorescence protein adsorbed on wild type and mutant spores of Bacillus subtilis Mucosal vaccine delivery by non-recombinant spores of Bacillus subtilis.Development of a new tuberculosis vaccine: is there value in the mucosal approach?Aerosol immunisation for TB: matching route of vaccination to route of infection The combination of recombinant and non-recombinant Bacillus subtilis spore display technology for presentation of antigen and adjuvant on single spore.Epitope-specific CD4+, but not CD8+, T-cell responses induced by recombinant influenza A viruses protect against Mycobacterium tuberculosis infection.Mucosal Delivery of Fusion Proteins with Bacillus subtilis Spores Enhances Protection against Tuberculosis by Bacillus Calmette-Guérin.Vaccines as alternatives to antibiotics for food producing animals. Part 2: new approaches and potential solutions

P2860

Q36909492-EB255472-9126-49E9-8107-7CAA96812A25 Q37243836-FE5F5602-210F-4618-B01F-97252F6428F6 Q38238919-0007359F-3146-4B0D-A433-51B2642371D5 Q38262258-E41BF43B-9D9B-436C-B648-8669B259FF44 Q38338183-208E7F29-D708-4A78-9D66-CFB45DF12BB4 Q40050837-11C73B58-9A60-4BFE-9772-060F77195DB0 Q41645299-03032E80-64AF-4B57-829B-49A8D29ECFAB Q52338712-CC343F71-09EB-488D-A606-5D530B3C565E Q56892183-3BFEBA0F-5566-407C-92F7-7A427BAA30A5

P2860

Mucosal vaccination against tuberculosis using inert bioparticles.

http://www.wikidata.org/entity/Q37264883

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Mucosal vaccination against tuberculosis using inert bioparticles.

@en

Mucosal vaccination against tuberculosis using inert bioparticles.

@nl

type

label

Mucosal vaccination against tuberculosis using inert bioparticles.

@en

Mucosal vaccination against tuberculosis using inert bioparticles.

@nl

prefLabel

Mucosal vaccination against tuberculosis using inert bioparticles.

@en

Mucosal vaccination against tuberculosis using inert bioparticles.

@nl

P1433

Q37264883-D7F056E1-5E08-40F5-BB10-AE90B2142CA3

P1476

Q37264883-1F0C4650-001F-4B35-9348-0ECEB2A6A1C7

P2093

Q37264883-4250ED86-D30E-4192-8996-0B543EFC212B

Q37264883-4A7A94BF-0381-49C4-B645-7B1039683B93

Q37264883-7534A68C-6FB8-495F-BC7D-82287BB09810

Q37264883-9589CC41-A18F-441D-995E-E0C24150B0C8

Q37264883-CD77B0AE-AF1B-45FE-8323-053D02C59A57

Q37264883-DBFCD9D4-DDE5-4A2E-839F-7606C82679E5

Q37264883-E3D71291-32B8-44A8-94DA-A50AC136CEB0

P2860

Q37264883-09A260F9-FBE1-4247-AC4D-02B3E143ACA7

Q37264883-0AEA08AB-70D1-4787-9468-3F9E9F57E3E1

Q37264883-0EC26B50-0F9C-4131-AD42-AD4D5D636BA5

Q37264883-11B98CE2-A76D-4252-AAB9-5B2EB46B04A5

Q37264883-16A009C5-067A-491A-A462-07F15BF66432

Q37264883-21BBCBD8-CFD4-4A02-AE73-397DA1F62F55

Q37264883-27C5D567-1770-4529-9790-7EC4C06FB80E

Q37264883-28153BF3-06EB-4AE9-84E6-A2352AE3CBCC

Q37264883-2AC913BE-548C-4E3F-B8F9-DCCAAB333B31

Q37264883-31340A8B-E145-451E-A89E-6496964D4AC3

P304

Q37264883-042D0061-BF3C-44C5-ADB9-89B8CE335DEC

P31

Q37264883-299DAFA1-ADC9-45CC-8700-501287A58B21

P356

Q37264883-1C977F89-48DA-43DD-B03E-72E81CD9A2B7

P407

Q37264883-7A134A58-24C8-41B0-AF14-4F32BA59DEE9

P433

Q37264883-D771A230-4E0E-419F-B500-03710523819B

P478

Q37264883-7CCA13EE-A4B1-4CED-8A31-FA76897534D8

P577

Q37264883-E042132D-A206-42FD-A99E-29D0663D3A8C

P698

Q37264883-1F7BC074-6DFD-42EE-9673-C0B9B3479B0C

P921

Q37264883-AB7BF75C-E748-41CF-B90F-28E6E296F4D3

P932

Q37264883-226A0A7C-69F0-46C4-9287-80AAE8CB5038

P356

P1433

Infection and Immunity

P1476

Mucosal vaccination against tuberculosis using inert bioparticles.

@en

P2093

Andreas Hoppe

http://www.w3.org/2001/XMLSchema#string

Huynh A Hong

http://www.w3.org/2001/XMLSchema#string

Ilaria Pepponi

http://www.w3.org/2001/XMLSchema#string

Jen-Min Huang

http://www.w3.org/2001/XMLSchema#string

Laura Sibley

http://www.w3.org/2001/XMLSchema#string

Rajko Reljic

http://www.w3.org/2001/XMLSchema#string

Simon M Cutting

http://www.w3.org/2001/XMLSchema#string

P2860

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing

Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles

Tuberculosis vaccines: progress and challenges.

Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport.

DNA vaccination against tuberculosis: expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity.

Microparticles for intranasal immunization.

Immune-complex mimics as a molecular platform for adjuvant-free vaccine delivery.

Bacillus subtilis isolated from the human gastrointestinal tract.

A novel TB vaccine; towards a strategy based on our understanding of BCG failure.

P304

4071-4080

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.00786-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23959722

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

3811844

http://www.w3.org/2001/XMLSchema#string